Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification

Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification

Abstract Background Patient-derived xenograft (PDX) models are important tools in precision medicine and for the development of targeted therapies to treat cancer patients. This study aimed to evaluate our precision medicine strategy that integrates genomic profiling and preclinical drug-screening p...

Full description

Bibliographic Details
Main Authors: Doo-Yi Oh, Kyungsoo Jung, Ji-Young Song, Seokhwi Kim, Sang Shin, Yong-Jun Kwon, Ensel Oh, Woong-Yang Park, Sang Yong Song, Yoon-La Choi
Format: Article
Language:English
Published: BMC 2017-08-01
Series:BMC Cancer
Subjects:
Met
HER2
Patient-derived cells
Lung cancer
Online Access:http://link.springer.com/article/10.1186/s12885-017-3525-9

Internet

http://link.springer.com/article/10.1186/s12885-017-3525-9

Similar Items